Figure 7
OS estimates and 95% CI stratified by post-transplantation HCMV pp65-antigenemia in patients with an intermediate or adverse genetic disease category (P < .004). Tick marks indicate surviving patients.
OS estimates and 95% CI stratified by post-transplantation HCMV pp65-antigenemia in patients with an intermediate or adverse genetic disease category (P < .004). Tick marks indicate surviving patients.
